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Lymphotoxin b (LTb), a member of the tumor necrosis factor family, plays an important role in lymphoid organogenesis. In
order to determine whether LTb is involved in cellular immunity, we investigated the antiviral immune response of
LTb-deficient (LTb 2/2) mice to lymphocytic choriomeningitis virus (LCMV). Cytotoxic T lymphocyte (CTL) responses to
LCMV were severely diminished, leading to viral persistence in brain and kidney. However, major functions of LTb-deficient
T lymphocytes and dendritic cells were intact. Reconstitution of irradiated LTb 1/1 mice with LTb 2/2 bone marrow
induced a disorganized splenic structure, accompanied by impairment of the LCMV-specific CTL response. These data
indicate that the absence of LTb does not affect the intrinsic function of T lymphocytes or of dendritic cells but that the
structural integrity of the spleen is strongly associated with generation of antiviral immunity. © 1999 Academic PressKey Words: cell surface molecules; CTL; dendritic cells; lymphoid organization.
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tINTRODUCTION
Resolution of a viral infection depends on proper gen-
ration of cellular and humoral immune responses. We
nd others have studied lymphocytic choriomeningitis
irus (LCMV) infection of mice as a model to dissect the
eterminants of the immune response that lead to the
learance of acute infection or to the establishement of a
ersistent infection. Immunocompetent mice infected
ith the LCMV Armstrong strain mount a vigorous anti-
iral cytotoxic T lymphocyte (CTL) response that elimi-
ates virus by 14 days postinfection. Clearance of LCMV
rom the serum and organs is primarily mediated by the
D81 MHC class I-restricted antiviral CTL response
Byrne and Oldstone, 1984; Moskophidis et al., 1987). The
tudy of the immune response to LCMV in mice deficient
or certain immunomodulatory molecules such as inter-
eukin-2 (IL-2), interleukin-12 (IL-12), interferon receptors,
umor necrosis factor a (TNFa), or CD40L has revealed
arious contributions of these molecules to the antiviral
mmune response (Borrow et al., 1996; Cousens et al.,
995; Orange and Biron, 1996; Van den Broek et al.,
995). However, little is known about the potential mod-
lation of the antiviral response by molecules of the TNF
amily important in lymphoid organogenesis. More spe-
ifically, it is not known whether these molecules, in
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136ddition to their morphogenetic role, play a direct role in
ellular interactions leading to an antiviral CTL response.
The TNF family of receptors/ligands is composed of
olecules involved both in lymphoid organogenesis and
n transduction of activation/death signals (reviewed in
mith et al., 1994). TNF-like molecules involved in mor-
hogenesis include the TNF receptors, LTa, LTb, and the
Tb receptor (LTbR). The predominant complex LTa1b2
inds to the LTbR, whereas a minor form (Lta2b1) binds
o TNFR-p55 and -p75 (Browning et al., 1995; Crowe et
l., 1994; Fu¨tterer et al., 1998; Rennert et al., 1998). A
ewly identified member of the TNF family, LIGHT, is also
ligand for the LTbR (Mauri et al., 1998). Surface LTa/b
omplexes are expressed solely on activated lympho-
ytes, whereas the LTbR is found on a variety of tissues
f the myelomonocytic lineage, suggesting a potential
ole in the regulation of immune responses (reviewed in
are et al., 1995).
Recent studies using mouse strains deficient in TNFa,
Ta, LTb, or their receptors have demonstrated overlap-
ing roles of these factors in the development of sec-
ndary lymphoid organs. The LTa/b–LTbR interaction
articipates in the formation of lymph nodes and in the
rganization of the spleen, whereas both the LTa/b–
TbR and TNFa–TNFR interactions seem to be involved
n the organization of germinal centers and follicular
endritic cell (FDC) networks. LTa-, LTb-, and LTbR-
eficient mice show a disorganized splenic microarchi-
ecture as well as a lack of certain lymph node groups
Alimzhanov et al., 1997; Banks et al., 1995; De Togni et
a
c
f
I
a
1
a
m
a
d
c
m
m
c
s
1
h
m
d
T
m
I
r
a
i
c
T
s
n
m
e
n
T
s
d
i
L
h
g
i
(
a
3
a
e
a
1
i
i
r
m
i
r
q
q
t
t
1
137DEFECTIVE ANTIVIRAL IMMUNITY IN LTb-DEFICIENT MICEl., 1994; Fu¨tterer et al., 1998; Koni et al., 1997). This
ontrasts with the structural characteristics of mice de-
icient for TNFa, TNFR-p55 (type 1), and TNFR-p75 (type
I), which demonstrate a relatively intact splenic micro-
rchitecture in the presence of lymph nodes (Le Hir et al.,
996). Germinal centers and FDC networks are absent in
ll the LTa-, LTb-, LTbR-, TNFa-, and TNFRp55-deficient
ice (Fu¨tterer et al., 1998; Koni et al., 1997; Matsumoto et
l., 1996; Pasparakis et al., 1996). Studies of mice with
eficiencies in two or more TNF family members have
onfirmed redundancy and synergies with regard to for-
ation of lymphoid organs (Koni and Flavell, 1998).
The lack of follicular dendritic cell networks and ger-
inal centers in the various TNF-ligand deficient animals
onsistently results in a defective humoral immune re-
ponse (Fu et al., 1997; Fu¨tterer et al., 1998; Koni et al.,
997; Le Hir et al., 1996; Pasparakis et al., 1996). There is,
owever, little information concerning the role of these
olecules in cellular immunity. Therefore, in order to
etermine whether lymphotoxin-b plays a role in antiviral
cell immunity, we examined the immune response
ounted by LTb-deficient mice after infection with LCMV.
n LTb-deficient mice, we found severe defects in antivi-
al immunity. Depending on the virus dose and organ
nalyzed, viral clearance was delayed or ineffective. Sim-
lar immunological defects were observed in LTa-defi-
ient mice. This contrasts with an earlier study on LTa–
NF-deficient mice showing a low but effective CTL re-
ponse to LCMV (Eugster et al., 1996). Our study clearly
oted an ineffective immune response in LTa-deficient
FIG. 1. CTL generation after infection with LCMV ARM is reduced in
he amount of infectious virus given. (A) Kinetics of primary CTL activi
ime point). (B) Analysis of primary CTL generation in a 51Cr release ass
03, or 105 PFU ip (six mice per group).ice similar to that observed in LTb-deficient mice. PAnalysis of proliferative, cytolytic, and secretory prop-
rties of T cells and dendritic cells (DC) in vitro revealed
o intrinsic defect in the function of T cells or of DC.
hese results are consistent with the view that altered
plenic microarchitecture and the defects in lymph node
evelopment observed in LTb- and LTa-deficient mice
mpair antiviral immunity.
RESULTS
Tb-deficient mice show impaired cellular and
umoral responses after virus infection
To characterize the primary antiviral T cell response,
roups of 8 to 12 LTb 2/2 and LTb 1/1 mice were
noculated with LCMV ARM 1 3 105 plaque-forming units
PFU) intraperitoneally (ip). Splenocytes of at least three
nimals were harvested at specific time points between
and 45 days postinfection and tested for cytotoxic
ctivity in a 51Cr release assay. CTL generation was
asily demonstrated in LTb 1/1 animals, with peak CTL
ctivity between days 7 and 9 after LCMV infection (Fig.
A). In contrast, CTL generation was severely diminished
n LTb 2/2 animals. Similar results were obtained with
noculation of lower virus doses. In LTb 1/1 mice, CTL
esponses were rapidly generated after infection of ani-
als with 1 3 102 or 1 3 103 PFU of LCMV ip. However,
n LTb 2/2 mice CTL responses were barely detectable
egardless of the amount of virus inoculated (Fig. 1B). To
uantitate the defect, we analyzed CTL precursor fre-
uency 60 days after infection with LCMV ARM 1 3 105
/2 mice compared to LTb 1/1 mice. This effect is not dependent on
infection with LCMV ARM 1 3 105 PFU ip (three mice per group and
ys after infection of LTb 2/2 and LTb 1/1 mice with LCMV ARM 102,LTb 2
ty after
ay 7 daFU ip (three mice per group). The number of LCMV-
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138 BERGER ET AL.pecific memory splenocytes was reduced by over
40-fold in LTb 2/2 mice (1:20,300 6 3420, mean 6
EM) compared to LTb 1/1 mice (1:140 6 11, mean 6
EM).
The generation of LCMV-specific humoral responses
as analyzed by enzyme-linked immunosorbent assay
ELISA). LCMV-specific IgG antibodies were easily de-
ected in LTb 2/2 mice. However, compared to LTb 1/1
ontrols, the serum titers were reduced by over sixfold
LTb 2/2 1:8000, LTb 1/1 1:52,000). Analysis of LCMV
eutralization by plaque reduction assay demonstrated
imilar levels of neutralizing antibodies in the sera from
nfected LTb 2/2 and LTb 1/1 animals at day 21 and
ay 72 postinfection.
T
Organ Titers of LCMV in LTb 2/2 and
Mouse strain
LCMV ARM
PFU ip Day postinfection S
LTb 2/2 102 54
100
LTb 2/2 103 54
100
LTb 2/2 105 54
100
170
LTb 1/1 102 54
100
LTb 1/1 103 54
100
LTb 1/1 105 54
100
FIG. 2. LTb 2/2 mice show delayed clearance of serum LCMV. LTb
/1 and LTb 2/2 mice were infected with LCMV ARM 1 3 105 PFU (15
nimals per group) or 1 3 103 PFU or 1 3 102 PFU ip (3 animals per
roup) and serum viral titers were determined by plaque assay at
arious time points postinfection.a Plaque assay on Vero cells.learance of LCMV is delayed in LTb-deficient mice
To analyze virus clearance after LCMV infection, infec-
ious virus was quantitated in sera, peripheral blood
ononuclear cells (PBMC), spleen, liver, kidney, heart,
ung, and brain of LTb 2/2 and LTb 1/1 animals at
arious time points. Viral titers were determined by
laque assay of sera and organ solutions on Vero cells.
fter inoculation with 1 3 105 PFU ip, LCMV ARM was
liminated from the serum of LTb 1/1 mice within 14
ays after infection. In contrast, LTb 2/2 animals dis-
layed delayed viral clearance. LCMV serum titers in-
reased up to two logs higher than those of LTb 1/1
ice and clearance was achieved 28 days later than for
Tb 1/1 animals (Fig. 2). Virus was cleared from serum
y day 42 postinfection. Virus elimination from the serum
f LTb 2/2 mice was dependent on the amount of virus
iven ip, as both the peak LCMV serum titers and the
umber of days necessary for viral clearance were re-
uced, if LCMV was inoculated at 103 or 102 PFU ip.
owever, once cleared, infectious virus did not return,
ince no recurrence of LCMV was detected during an
-month observation period.
Similar delayed clearance was observed for LCMV
rgan titers (Table 1). Repeated analyses of LCMV-in-
ected LTb 2/2 animals revealed elimination of LCMV
rom PBMC by day 72 postinfection and from spleen,
iver, lung, and heart by day 100. After infection with a
igh dose of LCMV ARM (1 3 105 PFU), infectious virus
as still found in the slow-clearing tissues, brain and
idney, on day 170 postinfection. It has been previously
hown that brain and kidney are slow to clear acute
CMV infection due to lack of expression of MHC class
molecules on neurons and to deposits of immune
/1 Mice at Different Doses of Virus
Organ titera (3103 PFU/g tissue)
Liver Kidney Heart Lung CNS
0 0 0 0 0
0 0 0 0 0
0 0.2 0 0 2.4
0 0 0 0 0
5.7 45 16 20 30
0 42 0 0 28
0 22 0 0 19
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0ABLE 1
LTb 1
pleen
0
0
0
0
21
0
0
0
0
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139DEFECTIVE ANTIVIRAL IMMUNITY IN LTb-DEFICIENT MICEomplexes in the kidney (Joly et al., 1991) (Buchmeier and
ldstone, 1978). However, in LTb 1/1 mice, virus was
bsent from all organs, including brain and kidney, by
ay 54 postinfection. Viral organ titers were dependent
n the amount of infectious virus given. After a low-dose
102 or 103 PFU ip) LCMV inoculation, LTb 2/2 animals
ere capable of clearing the infection from all organs.
hese results suggest that when lower doses of LCMV
ere inoculated, the small number of CTL generated in
Tb 2/2 mice was sufficient to clear virus.
We then analyzed whether fully functional and ade-
uately stimulated CTL were able to clear LCMV infec-
ion in an LTb-deficient environment. Memory spleno-
ytes from LTb 2/2 and LTb 1/1 mice were adoptively
ransferred to LTb 2/2 animals that had been inoculated
ith LCMV 14 days earlier. On day 28, recipients of LTb
/1 splenocytes had cleared the infection from serum,
nd by day 35 no virus was detectable in the organs
ncluding brain and kidney. In contrast, transfer of mem-
ry splenocytes from LTb 2/2 animals did not eliminate
CMV from the brain and kidney of LTb 2/2 recipients
ver a similar period of time (Table 2).
plenic T cell numbers are reduced in LTb 2/2 mice
ut in vitro function is intact
As the antiviral response to LCMV is dependent on the
eneration of MHC class I-restricted, CD81 cytotoxic T
ymphocytes, the number and function of T cells were
nalyzed in LTb 2/2 mice and LTb 1/1 controls. Total
plenocyte numbers were slightly lower in LTb 2/2
nimals. The proportion of CD81 T lymphocytes was also
hreefold less in LTb 2/2 animals in comparison to LTb
/1 animals as determined by FACS staining (Table 3).
owever, expansion of CD81 cells occurred to a similar
egree in both LTb 2/2 and LTb 1/1 animals 7 days
fter LCMV infection. There was no difference in the
ercentages of CD41 T cells between splenocytes from
TABLE 2
Adoptive Transfer of Memory Splenocytes from Wildtype Animals
Leads to Viral Clearance in LTb-Deficient Recipients
Splenocyte donor
typea
Recipient
typeb
Viral titerc (3103 PFU)
Serum day
28
CNS day
35
Kidney
day 35
LTb 1/1 LTb 2/2 0 0 0
LTb 2/2 LTb 2/2 9 10 16
None LTb 2/2 12 11 20
a 60 days after infection with LCMV ARM 1 3 105 PFU ip.
b 14 days after infection with LCMV ARM 1 3 105 PFU ip.
c Plaque assay on Vero cells, viral titers per milliliter of serum or per
ram of tissue.Tb 2/2 and LTb 1/1 animals (Table 3).Functional responses of LTb 2/2 splenocytes were
hen examined after nonspecific stimulation. [3H]Thymi-
ine incorporation was measured after stimulation of
plenocytes with anti-CD3 and anti-CD28 monoclonal
ntibodies. Proliferation was comparable for LTb 2/2
nd LTb 1/1 cells (Fig. 3A). The LCMV-specific second-
ry memory CTL response was also functional (Fig. 3B)
s splenocytes could be stimulated in vitro to lyse in-
ected targets in a secondary 51Cr release assay. These
esults confirm that, although present in lower numbers
n LTb 2/2 mice, functional LCMV-specific memory T
ells can be specifically activated by adequate stimula-
ion in vitro.
To further assess T cell function, cytokine production
rom both infected and uninfected LTb 2/2 and LTb
/1 splenocytes was studied after in vitro stimulation
ith PMA/ionomycin, anti-CD3/anti-CD28, or LCMV-in-
ected LTb 1/1 macrophages. After PMA/ionomycin
timulation, secretion of interferon-g (IFN-g) was fourfold
ess in LTb 2/2 splenocytes compared to LTb 1/1
plenocytes, whereas the level of IL-2 secretion was
omparable (Fig. 4A). When splenocytes were stimulated
pecifically on LCMV-infected LTb 1/1 macrophages,
nly splenocytes from day 7 infected LTb 1/1 mice
roduced detectable amounts of IFN-g (40 6 5 ng/ml),
hereas splenocytes from day 7 infected LTb 2/2 mice
id not. Flow cytometry staining for CD8 and IFN-g, after
nti-CD3/anti-CD28 stimulation of splenocytes on day 42
ostinfection, showed that 11.5% of LTb 2/2 splenocytes
xpressed CD8 and 13% of these CD81 cells (1.5% of
otal splenocytes) were producing IFN-g. In contrast, 26%
f LTb 1/1 splenocytes expressed CD8 and 53% of
hese CD81 cells (14% of total splenocytes) were produc-
ng IFN-g (Fig. 4B). This indicated that although LTb 2/2
plenocytes could be nonspecifically stimulated to pro-
uce cytokines, CD8 T cells were less efficient at pro-
ucing IFN-g.
plenic dendritic cell numbers are reduced in LTb
/2 mice but in vitro functions are retained
The normal responsiveness of T cells in vitro sug-
ested that altered antigen presentation might be re-
TABLE 3
Splenic T Cell Subtypes of LTb-Deficient and Wildtype Mice
Mouse type LCMV ARM CD41 %a CD81 %a
LTb 2/2 Uninfected 37.5 6 3.1 3.0 6 1.7
LCMV-infectedb 32.0 6 7.0 14.0 6 1.0
LTb 1/1 Uninfected 37.0 6 3.4 7.5 6 0.05
LCMV-infectedb 41.5 6 6.0 45.0 6 2.6
a Mean 6 SEM.
b Day 7 after infection with LCMV ARM 1 3 105 PFU ip.
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140 BERGER ET AL.ponsible for the defect in CTL generation in vivo. In
rder to test this possibility, we analyzed the number and
unction of dendritic cells in LTb 2/2 and LTb 1/1 mice.
pleens, bone marrow, and lymph nodes of groups of 10
ice each were processed individually as described
nder Materials and Methods. LTb 2/2 mice showed
wofold less total splenic DC (137,500 6 11,880, mean 6
EM) than LTb 1/1 animals (337,500 6 27,550). Age of
he animals (58.3 6 12.3 days) and spleen weight (0.14 6
.02 g) were similar in both groups. Dendritic cell sub-
ypes were analyzed by FACS analysis after staining for
yeloid (33D11) and interdigitating (NLDC1451) den-
ritic cells (Fig. 5A). The fraction of splenic NLDC1451
DC was significantly higher in LTb 2/2 mice (26.9 6
.2%, mean 6 SEM) than in LTb 1/1 animals (7.9 6
.5%). In contrast, the yield of dendritic cells as well as
he pattern of DC subtypes isolated from bone marrow or
esenteric lymph nodes did not reveal any significant
ifferences (data not shown).
Dendritic cell function was then studied in an alloge-
eic mixed lymphocyte reaction (MLR) and in a second-
ry CTL assay. In the MLR, splenic DC from LTb 2/2
nd LTb 1/1 mice were able to stimulate allogeneic T
ells equally well (data not shown). For the secondary
TL assay, splenic DC and peritoneal macrophages from
Tb 2/2 and LTb 1/1 animals were infected with
CMV and used to stimulate memory splenocytes from
Tb 1/1 mice. In order to exclude the effect of possible
ontaminating APC in the memory splenocyte popula-
ions, both bulk splenocytes and fractions enriched for
D81 with a purity of 99% were used. LCMV-infected
FIG. 3. Splenocytes from LTb 2/2 animals respond appropriately to
rom noninfected mice (NI) or at day 50 postinfection (d50). Cells we
easured by [3H]thymidine incorporation with three mice per group. (B)
ssay after in vitro stimulation on LCMV-infected macrophages for 7
ubtracted. Splenocytes were harvested 60 days after inoculation of Lplenic DC from both LTb 2/2 and LTb 1/1 animals showed clear stimulation of secondary CTL in a 51Cr
elease assay (Fig. 5B). The infected DC from both types
f animals stimulated secondary CTL as well as the
nfected macrophages did. This indicated that APC func-
ion of DC from LTb 2/2 mice is intact.
Dendritic cell function was further studied by analysis
f IL-12 secretion from DC preparations after stimulation
ith LPS. Splenic DC from LTb 2/2 and LTb 1/1
nimals were isolated to a purity of .85% as determined
y FACS analysis. Secretion of IL-12 from LTb 2/2
nimals was reduced by 40%, as determined by ELISA.
his was independent of LCMV infection as both unin-
ected mice and mice infected 5 days earlier with LCMV
howed decreased IL-12 production (Fig. 5C).
Tb-deficient bone marrow cells induce splenic
isorganization and impair antiviral CTL response
To further analyze the relation between LTb deficiency,
pleen structure, and antiviral immunity, studies in bone
arrow chimeric mice were performed. Bone marrow
rom LTb 2/2 or LTb 1/1 mice was prepared as a
ingle-cell suspension and given intravenously to irradi-
ted LTb 1/1 recipients to reconstitute hematopoiesis
LTb1/1*LTb2/2 and LTb1/1*LTb1/1, respectively).
he LTb1/1*LTb2/2 bone marrow chimeras represent
model of LTb 2/2 hematopoietic cells in a normal (LTb
/1) environment and allow for distinction of develop-
ental and cellular defects due to LTb deficiency. LTb1/
*LTb1/1 chimeras were generated as controls.
LTb1/1*LTb2/2 bone marrow chimeric mice
ic and nonspecific stimulation in vitro. (A) Proliferation of splenocytes
pecifically stimulated with anti-CD3/anti-CD28 and proliferation was
f LCMV-infected syngeneic target cells was measured by a 51Cr release
ackground values of lysis of uninfected syngeneic target cells were
RM 1 3 105 PFU ip from three mice per group.specif
re nons
Lysis o
days. Bhowed a disorganized spleen structure. Immunohisto-
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141DEFECTIVE ANTIVIRAL IMMUNITY IN LTb-DEFICIENT MICEhemical staining of macrophages and dendritic cells
evealed disruption of the marginal zone (data not
hown). CTL generation was severely impaired (Fig. 6).
ssessment of viral serum titers demonstrated delayed
iral clearance; infectious virus was still present at day
8 postinfection. In contrast, LTb1/1*LTb1/1 control
one marrow chimeras retained a normal spleen struc-
ure, efficiently generated CTL, and cleared LCMV from
he serum by day 14 after virus inoculation. As a com-
arison, CTL responses of LTb 2/2 and LTa 2/2 mice
ere analyzed. Figure 6 shows that at day 9 postinfec-
ion, little to no CTL activity was detected in LTb 2/2 or
Ta 2/2 mice. Furthermore, LCMV-infected LTa 2/2
FIG. 4. IFN-g secretion of CD81 T cells is decreased in splenocyt
noculation of mice with LCMV ARM 1 3 105 PFU ip) or noninfected mic
ith PMA/ionomycin and supernatants were analyzed for IL-2 and IFN-
2 post-LCMV infection were stimulated with anti-CD3 and anti-CD28
epresentative of experiments carried out on three mice/group.ice showed high serum virus titers and impaired clear- nnce of LCMV similar to LCMV-infected LTb 2/2 mice
data not shown).
DISCUSSION
This study demonstrates that mice deficient in LTb
xpression are severely impaired in their ability to gen-
rate an LCMV-specific CTL response. LCMV serum
iters are poorly controlled early in infection and virus
learance is delayed. We found no intrinsic defect in the
bility of T cells to proliferate or acquire CTL activity nor
n the dendritic cells to act as APC. However, the early
ysfunction of the immune response resulting in low
LTb 2/2 mice. (A) Splenocytes from LCMV-infected (7 days after
cultured in vitro for 48 h. Splenocytes were stimulated nonspecifically
tion by ELISA. (B) Splenocytes from LTb 1/1 or LTb 2/2 mice at day
tained with specific antibodies for CD8 and IFN-g. The dot plots arees from
e were
g secre
and sumbers of LCMV-specific CTL led to impaired produc-
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142 BERGER ET AL.ion of IL-12 and IFN. A lower level of these cytokines
annot in itself account for the impaired clearance of
cute LCMV. Thus, this study shows the importance of
Tb in maintaining a splenic environment capable of
enerating an effective antiviral immune response.
Infection of LTb 2/2 mice with LCMV (105 or 103 PFU
p) led to a 100-fold increase in serum virus titers at day
postinfection compared to virus titers in LTb 1/1 mice.
his suggests that early mechanisms of control of virus
eplication are not functioning in LTb 2/2 mice. IFN type
FIG. 5. Splenic dendritic cells from LTb 2/2 mice show intact antig
raction of interdigitating DC than do LTb 1/1 mice. (A) Splenic DC
NLDC-145) prior to FACS analysis. Histograms show CD86hi cells only.
ere harvested from LTb 2/2 and LTb 1/1 animals and cocultured fo
nfection with LCMV ARM 1 3 105 PFU ip). Both bulk splenocytes and
ysis of infected syngeneic targets in a 51Cr release assay. No lysis
CMV-infected (5 days after inoculation) LTb 2/2 and LTb 1/1 mice
ith LPS in vitro and IL-12 secretion was determined 48 h later by ELand to a lesser degree IFN-g have been shown to Control early replication of acute LCMV infection (Huang
t al., 1993; Van den Broek et al., 1995). It has been
uggested that effective IFN-a/b producing cells localize
o the marginal zones surrounding the splenic follicles
Eloranta et al., 1996). Thus the lack of marginal zone
acrophages (MZM) and metallophilic macrophages
MM) observed in LTb 2/2 mice may lead to insufficient
evels of IFN-a/b, which are unable to control early viral
eplication. Studies of the LCMV response in mice chem-
cally depleted of MZM and MM have shown impaired
senting function although they secrete less IL-12 and show a higher
isolated as described and stained for both B7.2/CD86 and DEC-205
nic dendritic cell (DC) preparations and peritoneal macrophages (Mf)
s with memory splenocyte effectors from LTb 1/1 mice (45 days after
s enriched for CD81 CTL were used. Effector function was studied as
nfected targets was observed. (C) Splenocytes from uninfected and
arvested and enriched for dendritic cells. Splenic DC were stimulated
ee mice per group).en-pre
were
(B) Sple
r 7 day
fraction
of uni
were hTL generation, uncontrolled replication of LCMV, and
d
b
c
a
a
e
L
1
i
s
t
m
c
c
s
m
c
o
p
A
o
m
t
t
t
t
c
c
t
2
I
2
r
w
s
c
A
w
p
u
g
o
t
a
i
T
i
p
t
t
b
i
r
o
p
m
l
g
b
l
r
c
r
m
v
a
L
r
t
a
d
t
m
i
d
r
M
l
w
H
c
o
s
o
g
m
a
a
m
m
C
P
L
143DEFECTIVE ANTIVIRAL IMMUNITY IN LTb-DEFICIENT MICEelayed viral clearance (Seiler et al., 1997). It has also
een demonstrated in various mouse models that un-
ontrolled LCMV replication can lead to an ineffective
ntiviral immune response. Infection of adult mice with
n immunosuppressive variant of LCMV ARM, clone 13,
licits a very low CTL response, results in high titers of
CMV, and leads to persistent infection (Ahmed et al.,
984; Oldstone et al., 1988; Salvato et al., 1988). This virus
nfection, in conjunction with LCMV-specific CD81 CTL,
pecifically leads to the destruction of splenic interdigi-
ating dendritic cells (Borrow et al., 1995). As LTb 2/2
ice have approximately 3-fold fewer splenic CD8 T
ells and dendritic cells than do LTb 1/1 mice, poorly
ontrolled LCMV titers may overwhelm the CTL re-
ponse more quickly in these mice than in other mouse
odels. During the persistent infection initiated by LCMV
lone 13, virus is present both in the serum and in all
rgans (Oldstone et al., 1988). In contrast, during the viral
ersistence established in LTb 2/2 mice after LCMV
RM infection, virus is present at day 170 postinfection
nly in the brain and kidney and only after inoculation of
ice with 1 3 105 PFU ip. This suggests that the persis-
ence of LCMV in LTb 2/2 mice is not likely due to a
ruly lifelong persistent infection but rather to an ex-
remely slow viral clearance process.
The low CTL response in LTb 2/2 mice was not due
o an intrinsic defect in T cells, since LTb 2/2 CD81 T
ells demonstrated intact proliferative, cytolytic, and se-
retory responses. The splenocyte proliferative response
o anti-CD3/anti-CD28 stimulation was similar in LTb
/2 and in LTb 1/1 mice. However, the cytolytic and
FN-g secretion capabilities of CD81 T cells from LTb
/2 mice were depressed. Since CD81 T lymphocyte
esponses from LTb 2/2 mice were decreased in vitro,
e analyzed various functions of splenic antigen-pre-
FIG. 6. Reconstitution of LTb 1/1 mice with LTb 2/2 bone marrow
bolishes CTL response. Splenocytes from chimeras of LTb 2/2 bone
arrow into LTb 1/1 (LTb1/1*LTb2/2) mice and of LTb 1/1 bone
arrow into LTb 1/1 (LTb1/1*LTb1/1) animals were assayed for
TL activity, by a 51Cr release assay, 9 days after infection with 1 3 105
FU of LCMV ARM ip. For comparison, CTL activity of splenocytes from
Tb 2/2 and LTa 2/2 mice was analyzed.enting cells. DC were able to stimulate memory spleno- cytes in a secondary CTL assay, thus showing proper
PC function. However, splenic DC from LTb 2/2 mice
ere inhibited by approximately 40% in their ability to
roduce IL-12 in response to in vitro LPS stimulation. It is
nlikely that the decreased capacity to produce IL-12
reatly contributes to the defective anti-LCMV response
bserved in LTb 2/2 mice, as studies have suggested
hat IL-12 does not play as important a role in initiating an
nti-LCMV response as it does in certain other viral
nfections (Orange and Biron, 1996; Oxenius et al., 1999).
he significance of a threefold higher percentage of
nterdigitating DC observed in LTb 2/2 spleens com-
ared to LTb 1/1 spleens is unknown. Taken together,
he results concerning T cell and DC function suggest
hat LTb is not involved directly in the immune response
ut that a specific balance of DC subtypes and cellular
nteractions within a proper splenic environment may be
equired to maintain CD81 T cells and DC cells in a state
f optimum responsiveness.
Our results and those of others strongly suggest that
roper splenic follicle structure, presence of an intact
arginal zone, and compartmentalization of T and B
ymphocyte areas in the white pulp are necessary to
enerate an effective CTL response. LTa 2/2 and dou-
le LTa–TNFa-knockout mice possess many of the same
ymphoid organ defects as LTb 2/2 mice including dis-
upted marginal zone and splenic follicles. Eugster and
o-workers showed that a minimal LCMV-specific CTL
esponse was generated in double LTa–TNFa-deficient
ice after intravenous (iv) infection with LCMV, clearing
irus from all organs by day 20 postinfection (Eugster et
l., 1996). Results from our laboratory, similarly, show that
Ta 2/2 mice generate a weak CTL response compa-
able to that seen for LTb 2/2 mice. However, contrary
o Eugster et al. (1996), we find that the serum virus titer
nd kinetics of LCMV clearance in LTa 2/2 mice are
elayed as much as for LTb 2/2 mice. Discrepancies in
he kinetics of viral clearance between the two studies
ay in part be due to different virus doses and routes of
nfection.
Recent work has shown that the splenic structural
efects of mice deficient in LTa can be reversed after
econstitution with wildtype bone marrow (Fu et al., 1997;
uller et al., 1996). These studies addressed splenic and
ymph node structure as well as humoral immunity,
hereas defects in cellular immunity were not analyzed.
owever, our studies of immune defects in bone marrow
himeras show that the transition from a phenotype of
rganized splenic structure (LTb 1/1) to a phenotype of
plenic disorganization was accompanied by impairment
f the LCMV-specific CTL response. These studies sug-
est that the impaired immune response of LTb 2/2
ice is due to disrupted splenic architecture. However,
s spleenless Hox 11 2/2 mice have been shown to
lear a viral infection (Karrer et al., 1997), we cannot
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144 BERGER ET AL.xclude the importance of lymph nodes in the antiviral
esponse. It is not clear whether Hox 11-deficient mice
ave developed compensatory mechanisms for lacking a
pleen during ontogeny or whether lymph nodes alone
an actually clear virus infection. However, despite the
resence of mesenteric and cervical lymph nodes in LTb
/2 mice, they fail to mount an effective antiviral re-
ponse. Because of compensatory mechanisms and re-
undancies in immune function, further studies in vari-
us genetically modified animal models will be neces-
ary to determine the respective contributions of lymph
odes and of spleen to an antiviral immune response.
The natural mutant aly/aly is another model of dis-
upted splenic architecture. The aly/aly mice have the
ame splenic defects as LTb 2/2 mice and do not
enerate an effective CTL response to LCMV (Karrer et
l., 1997). By contrast, the TNFR1 2/2 mice, which dis-
lay a more organized splenic structure and marginal
ones than do LTb 2/2 mice, can mount an effective
TL response to LCMV (Rothe et al., 1994). Overall, the
ly/aly, LTa 2/2, and LTb 2/2 mouse models share
plenic disorganization patterns and are unable to mount
n effective CTL response. It will be interesting to deter-
ine the role of the marginal zone in the induction of the
mmune response since this region is both the port of
ntry to the splenic follicles and a MM-, MZM-, and
C-rich zone capable of producing IFN-a/b. Further-
ore, the development of future models demonstrating
ntermediate levels of splenic disorganization should
elp to define the minimum splenic structure required to
romote correct interactions between the cells involved
n an effective antiviral immune response.
MATERIALS AND METHODS
ice
LTb-deficient mice (LTb 2/2) and LTb 1/1 mice
expanded from original littermates of LTb 2/2 mice)
ere described previously (Koni et al., 1997). LTa 2/2
ice were derived originally by David Chaplin (Washing-
on University, St. Louis, MO) (De Togni et al., 1994). All
ice were on a mixed background of C57BL/6 and 129/
v. Breeding and maintenance were performed under
pecific pathogen-free conditions at the Rodent Breeding
olony, Scripps Research Institute (La Jolla, CA) and at
ale University (New Haven, CT).
one marrow chimeras
LTb 1/1 recipients (8 weeks of age) were total body
rradiated with 1100 rad 1 day prior to transplantation.
one marrow from LTb 2/2 and LTb 1/1 donor mice
as prepared as a single-cell suspension from the fe-
urs of the animals, and each LTb 1/1 recipient wasnjected intravenously with a total of 2 3 106 nucleated (arrow cells in 0.2 ml of PBS. Analysis of antiviral im-
unity and spleen structure was performed 8 weeks
fter transplantation.
irus, virus quantitation, and infection of mice
The virus used was the Armstrong 53b strain (ARM) of
CMV. Virus origin, sequence, growth in baby hamster
idney cells, and titration by standard plaque assay have
reviously been described (Dutko and Oldstone, 1983;
alvato et al., 1988). Depending on the experiment, mice
ere 6 to 10 weeks of age at the time of virus infection.
nfections were carried out by ip inoculation of 1 3 102,
3 103, or 1 3 105 PFU of LCMV ARM in a volume of 0.2
l.
TL generation and precursor frequency
LCMV-specific primary CTL activity of splenocytes
rom mice infected with LCMV ARM ip was assessed in
standard 5-h 51Cr release assay as described by Byrne
nd Oldstone (1984). Splenocytes were harvested at spe-
ific times between 5 and 45 days postinfection as
tated. Effector:target ratios of 50:1, 25:1, and 12:1 were
sed on LCMV-infected and noninfected target cells. For
etermination of LCMV-specific memory CTL activity
CTL precursor analysis), splenocytes from LCMV-in-
ected mice were harvested 45 days after virus inocula-
ion, plated in serial dilutions, restimulated in vitro on
CMV-infected LTb 1/1 macrophages, and tested for
ytolytic activity in an in vitro 51Cr release assay. Calcu-
ation of CTL precursors was performed as described
Byrne and Oldstone, 1984; McDonald et al., 1980).
ntiviral antibody levels
Antiviral antibody levels were determined by ELISA,
ased on a method described by Ahmed et al. (1984).
riefly, 96-well plates were coated with LCMV, and se-
um samples from infected mice were assayed for the
resence of LCMV-specific IgG using a horseradish-
eroxidase-conjugated anti-mouse IgG and appropriate
ubstrate (Cappel Research Products, Durham, NC).
CMV-neutralizing antibody was measured by plaque
eduction assay. Serial dilutions of sera from infected
ice were incubated for 30 min with 200 PFU LCMV
RM at 37°C. Standard plaque assay was then carried
ut and neutralizing activity determined.
ytokine secretion
For quantitation of cytokine secretion, splenocytes
ere harvested 7 days after infection of mice with LCMV,
ultured in the presence of medium containing PMA (5
g/ml) and ionomycin (500 ng/ml) (Sigma), uninfected
acrophages, or LCMV-infected LTb 1/1, irradiated1800 rad) macrophages. For IL-12 detection, dendritic
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145DEFECTIVE ANTIVIRAL IMMUNITY IN LTb-DEFICIENT MICEell preparations were stimulated with LPS. Supernatant
as collected 48 h later for analysis in a sandwich ELISA
all antibodies and standards from PharMingen, La Jolla,
A). Plates were coated overnight at 4°C with capture
ntibodies against IFN-g, IL-2, and IL-12. After washing
nd blocking with 10% fetal calf serum in PBS, serial
ilutions of supernatants were incubated overnight at
°C. Subsequently, plates were washed and incubated
or 1 h with matched biotinylated detection antibodies.
ncubation for 30 min with a streptavidin:peroxidase con-
ugate (1:1000) (Boehringer Mannheim, Indianapolis, IN)
as followed by the color reaction with H2O2-activated
,29-azino-di-[3-ethylbenzthiazolin-6-sulfonic acid (Sigma,
t. Louis, MO) in 0.1 M citric acid. Plates were read at 405
m with an EL-800 microplate reader (Biotek, Winooski,
T) using DeltaSoft 3 (BioMetallics, Princeton, NJ).
doptive transfers
To determine whether memory cells from LTb 1/1
ice were able to clear persistent LCMV infection of the
rain and kidney in LTb 2/2 animals, erythrocyte-de-
leted splenocyte suspensions were prepared from do-
or LTb 1/1 mice 60 days after infection with LCMV
RM. Recipient LTb 2/2 mice had been infected with
CMV ARM 1 3 105 PFU ip 14 days prior to the adoptive
ransfer. A total of 3 3 107 donor splenocytes were
ransferred into irradiated (300 rad) recipients by ip in-
ection in 0.3 ml of PBS. Analysis of serum viral titers was
erformed 7, 14, and 21 days after the transfer; organ
iters were assessed after 21 days.
ACS analyses
Staining of cell surface antigens was performed by
ncubating cells for 30 min at 4°C in the presence of
aN3, with an unlabeled primary antibody or with a
luorochrome-conjugated primary antibody. After wash-
ng, for DC staining, cells were incubated with a second-
ry fluorescein-conjugated antibody for 30 min at 4°C,
ashed, and analyzed on a FACSort (Becton-Dickinson).
or T cell staining, Cy-Chrome-CD4 and APC-CD8 were
sed (PharMingen). For analysis of dendritic cells, a
rimary monoclonal antibody against B7.2/CD86 (Phar-
ingen) and hybridoma supernatants against myeloid
C (hybridoma 33D1) and interdigitating DC (hybridoma
LDC-145 recognizing DEC-205) were used. Intracellular
ytokine staining was done after stimulation of spleno-
ytes with immobilized anti-CD3 antibody and soluble
nti-CD28 antibody. Cells were surface stained, fixed,
ermeabilized in PFA/saponin, and stained with a PE-
onjugated anti-IFN-g.
solation of antigen-presenting cells
Macrophages were harvested by peritoneal washes 3
ays after inoculation of mice with thioglycolate. Cells tere washed, plated in 24-well plates, and infected with
CMV ARM in vitro at an m.o.i. of 1. Dendritic cells were
solated from lymph nodes and spleen of LTb 2/2 and
Tb 1/1 mice as previously described (Crowley et al.,
990). Briefly, spleens or lymph nodes of uninfected or
CMV-infected mice were digested with collagenase D
Boehringer Mannheim, Indianapolis, IN) and separated
nto fractions of low and high buoyant density on dense
ovine serum albumin (Cohn fraction V, Intergen) col-
mns. Dendritic cells of the low-density fractions were
urther enriched by plastic adherence for 16 h. Dendritic
ells were enriched by erythrocyte depletion (ammonium
hloride lysis) and subsequent culture for 7 days in RPMI
640 medium with 5% heat-inactivated fetal bovine se-
um, 10 mM HEPES, 20 mg/ml gentamicin sulfate, 50 mM
-mercaptoethanol, and 20 ng/ml murine recombinant
M-CSF. Cell counts were determined by trypan blue
xclusion.
ntigen presentation assay
Antigen presentation function was analyzed for
plenic dendritic cells and peritoneal macrophages from
Tb 2/2 and LTb 1/1 animals. Splenic DC and perito-
eal macrophages were isolated as described above
nd cocultured, at a ratio of 1:20, with bulk splenocytes
r purified CD81 T cells from mice infected with LCMV
RM 1 3 105 PFU ip 45 days earlier. Enrichment of CD81
cells was performed using a magnetic separation tech-
ique. Briefly, splenocytes were incubated for 15 min
ith a cocktail containing antibodies against CD11b,
D45R, CD4, myeloid differentiation antigen Gr-1, and
ER-119 (Stem Cell Technology, Vancouver, BC, Canada).
fter being washed in PBS, cells were resuspended with
n anti-biotin tetramer and magnetic colloid, passed
hrough a column, and placed in a magnetic device to
emove non-CD81 cells. Purity of enriched cells was 99%
ith less than 0.05% CD41 T cells as determined by
ACS analysis. After in vitro activation, LCMV-specific
TL activity of bulk splenocytes and enriched CD81 CTL
as assessed in a standard 5-h 51Cr release assay on
CMV-infected and uninfected MC57 and Balb/c17 cells
s described above.
tatistical analyses
Two-tailed t tests were performed for calculation of
tatistical significance using Prism 2.01 (GraphPad Soft-
are, San Diego, CA).
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